STOCK TITAN
  1. Home
  2. Sec-filings
  3. IMMX
  4. [EFFECT] Immix Biopharma, Inc. SEC Filing

[EFFECT] Immix Biopharma, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 22, 2026 5:00 P.M.
Form: S-3
CIK: 0001873835
Company Name: Immix Biopharma, Inc.
File Number: 333-292665

Source: View Original Filing on SEC EDGAR

Stock IMMX logo
Immix Biopharma Inc

NASDAQ:IMMX

IMMX Rankings

#4149 Ranked by Market Cap
N/A Ranked by Dividends
#107 Top Loser

IMMX Latest News

Dec 9, 2025
Immix Biopharma Announces Closing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Dec 7, 2025
Immix Biopharma Announces Pricing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Dec 7, 2025
At ASH 2025 Oral Presentation, Immix Biopharma Reports Positive Phase 2 NXC-201 Results, Advancing Toward BLA Submission as a Potentially First- and Best-in-Class Therapy for relapsed/refractory AL Amyloidosis
Nov 12, 2025
Immix Biopharma Appoints Chief Commercial Officer to Drive NXC-201 Launch
Nov 3, 2025
Immix Biopharma’s NXC-201 NEXICART-2 Clinical Trial Results Selected for Oral Presentation at ASH 2025

IMMX Latest SEC Filings

Jan 9, 2026
[S-3] Immix Biopharma, Inc. Shelf Registration Statement
Dec 11, 2025
[Form 4] Immix Biopharma, Inc. Insider Trading Activity
Nov 26, 2025
[8-K] Immix Biopharma, Inc. Reports Material Event
Nov 7, 2025
[10-Q] Immix Biopharma, Inc. Quarterly Earnings Report
Oct 6, 2025
[S-3] Immix Biopharma, Inc. Shelf Registration Statement

IMMX Stock Data

278.01M
40.49M
34.4%
8.46%
1.28%
Biotechnology
Pharmaceutical Preparations
Link
United States
LOS ANGELES